Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells
About this item
Full title
Author / Creator
Kline, Kathryn , Luetkens, Tim , Koka, Rima , Kallen, Michael E. , Chen, Wengen , Ahmad, Haroon , Omili, Destiny , Iraguha, Thierry , Gebru, Etse , Fan, Xiaoxuan , Miller, Alexis , Dishanthan, Nishanthini , Baker, Jillian M. , Dietze, Kenneth A. , Hankey, Kim G. , Yared, Jean A. , Hardy, Nancy M. , Rapoport, Aaron P. , Dahiya, Saurabh and Atanackovic, Djordje
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Background
Aggressive B cell lymphoma with secondary central nervous system (CNS) involvement (SCNSL) carries a dismal prognosis. Chimeric antigen receptor (CAR) T cells (CAR-T) targeting CD19 have revolutionized the treatment for B cell lymphomas; however, only single cases with CNS manifestations successfully treated with CD19 CAR-T have been...
Alternative Titles
Full title
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells
Authors, Artists and Contributors
Author / Creator
Luetkens, Tim
Koka, Rima
Kallen, Michael E.
Chen, Wengen
Ahmad, Haroon
Omili, Destiny
Iraguha, Thierry
Gebru, Etse
Fan, Xiaoxuan
Miller, Alexis
Dishanthan, Nishanthini
Baker, Jillian M.
Dietze, Kenneth A.
Hankey, Kim G.
Yared, Jean A.
Hardy, Nancy M.
Rapoport, Aaron P.
Dahiya, Saurabh
Atanackovic, Djordje
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10864416
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10864416
Other Identifiers
ISSN
1432-0851,0340-7004
E-ISSN
1432-0851
DOI
10.1007/s00262-023-03619-9
